SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?


To: Bharat H. Barai who wrote (726)7/21/1998 4:36:00 PM
From: Bill Wexler  Respond to of 834
 
The problem is not *really* with Novastan (though it is only an existing drug repackaged fro a new indication), the problem really lies with TXB management, their fraudulent stock promotion activities and their lack of R&D infrastructure (resulting in sloppy clinical work.